7 F-Rated Stocks for Your August 2024 Sell List
There’s nothing wrong with trying to get in early on a stock. Some of your best winners will be companies you identify before the rest of the pack – that’s why investors spend a lot of time rese...
- Supported exchanges /
- NASDAQ /
- TLSA.NASDAQ
Tiziana Life Sciences Ltd (TLSA NASDAQ) stock market data APIs
$1.01
0(0%)
as of December 9, 2024
Price chart is built with Anychart
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), an orally bioavailable small molecule broad spectrum inhibitor of various cyclin-dependent kinases and Src family; and TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.
Tiziana Life Sciences Ltd Financial Data Overview
| 1.01 | |
| 1.01 | |
| - | |
| 1.06 | |
| 0.98 | |
| 0.41-1.74 | |
| 105 M | |
| 104 M | |
| -3 595 000 | |
| -0.05 | |
| 0.178 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'TLSA',
Type:
'Common Stock',
Name:
'Tiziana Life Sciences Ltd',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG0129Q42X2',
ISIN:
'BMG889121031',
CUSIP:
'88875G101',
CIK:
NULL,
EmployerIdNumber:
'',
FiscalYearEnd:
'December',
IPODate:
'2000-03-24',
InternationalDomestic:
'International/Domestic',
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
'ADR',
IsDelisted:
false,
}
Tiziana Life Sciences Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue -3 595 000
- EBITDA -15 788 000
- Earnings Per Share -0.13
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Tiziana Life Sciences Ltd Earnings via APIs
- Latest Release 2022-12-27
- EPS/Forecast 0
Get Tiziana Life Sciences Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Tiziana Life Sciences Ltd latest news via APIs
The 7 Smartest Cathie Wood Stocks to Buy With $10K Right Now
Cathie Wood, known for her bold investment strategies through ARK Invest, continues to captivate the financial world with her stock picks. As of 2024, she remains focused on innovative and disruptive ...
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
